ETON — Eton Pharmaceuticals Inc
In 2026 Q2, 5 of the 140 tracked hedge funds reported a position in Eton Pharmaceuticals Inc (ETON), worth $10.90M combined. Over the quarter 3 opened or added, 2 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Panoramic | $7.54M | 3.20% | +12.5% |
| Renaissance | $1.89M | 0.00% | -68% |
| Essex | $728.74K | 0.10% | -0.3% |
| Navellier | $651.96K | 0.05% | NEW |
| Persistent | $90.25K | 0.03% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.